Synapse - Works

Results (3382)

A first-in-human phase I study of U3-1287 (AMG 888), a HER3 inhibitor, in patients (pts) with advanced solid tumors

Meeting Abstract

Berlin, J.; Keedy, V. L.; Janne, P. A.; Yee, L.; Rizvi, N. A.; Jin, X.; Copigneaux, C.; Hettmann, T.; Beaupre, D. M.; LoRusso, P.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Effect of sunitinib (SU) administration on post-treatment survival in patients with metastatic renal cell carcinoma (mRCC) treated on the upfront randomized phase III trial of sunitinib or interferon alfa (IFN)

Meeting Abstract

Blagoev, K. B.; Wilkerson, J.; Stein, W. D.; Motzer, R. J.; Bates, S. E.; Fojo, A. T.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Patient perspectives on a treatment plan and summary program in community oncology care

Meeting Abstract

Blinder, V. S.; Norris, V. W.; Peacock, N. W.; Griggs, J. J.; Harrington, D. P.; Moore, A.; Theriault, R. L.; Partridge, A. H.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Lymphodepletion and tumor burden govern clinical responses in patients with B-cell malignancies treated with autologous, CD19-targeted T cells

Meeting Abstract

Brentjens, R. J.; Riviere, I.; Park, J.; Davilla, M.; Wang, X.; Yeh, R.; Lamanna, N.; Frattini, M. G.; Sadelain, M.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Feasibility and yield of offering genetic counseling to all patients with newly diagnosed high-grade epithelial ovarian cancer

Meeting Abstract

Arnold, A. G.; Bhatia, J.; Phillips, M. F.; Gardner, G. J.; Bell-McGuinn, K. M.; Aghajanian, C.; Barakat, R. R.; Offit, K.; Kauff, N. D.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

First results from a phase I trial of AZD8055, a dual mTORC1 and mTORC2 inhibitor

Meeting Abstract

Banerji, U.; Aghajanian, C.; Raymond, E.; Kurzrock, R.; Blanco-Codesido, M.; Oelmann, E.; Grinsted, L.; Burke, W.; Kaye, S. B.; Naing, A.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Design of a phase II randomized, open-label trial of DN24-02, an autologous cellular immunotherapy targeting HER2/neu, in patients with surgically resected urothelial cancer at high risk of recurrence

Meeting Abstract

Bajorin, D. F.; Sharma, P.; Sims, R. B.; Sandler, A.; Lerner, S. P.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Fluorodeoxyglucose (FDG) positron emission tomography (PET) as an indicator of disease progression for patients with castration-resistant metastatic prostate cancer (CRMPC)

Meeting Abstract

Baklajian, A.; Dennis, E. R.; Buddle, J. R.; Fox, J. J.; Schoder, H.; Morris, M. J.; Larson, S. M.; Scher, H. I.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

To determine the predictive value of preoperative breast MRI in selecting patients appropriate for nipple-sparing mastectomy

Meeting Abstract

Barry, J. M.; de Alcantara Filho, P.; D'Arcy, C.; Stempel, M.; Sacchini, V.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save

Development of a guidance for including patient-reported outcomes (PROs) in post-approval clinical trials of oncology drugs for comparative effectiveness research (CER)

Meeting Abstract

Basch, E. M.; Abernethy, A. P.; Mullins, C. D.; Tiglao, M. R.; Tunis, S. R.
Journal of Clinical Oncology (2011)

Fulltext@MSK | Save